Thrombin enhances the adhesion and migration of human colon adenocarcinoma cells via increased beta 3-integrin expression on the tumour cell surface and their inhibition by the snake venom peptide, rhodostomin
- PMID: 8611404
- PMCID: PMC2074261
- DOI: 10.1038/bjc.1996.161
Thrombin enhances the adhesion and migration of human colon adenocarcinoma cells via increased beta 3-integrin expression on the tumour cell surface and their inhibition by the snake venom peptide, rhodostomin
Abstract
The interactions between tumour cells and the microvasculature, including the adhesion of tumour cells to endothelium and extracellular matrix (ECM) as well as their migratory ability, are prerequisites for metastasis to occur. In this study we showed that thrombin is capable of enhancing in vitro tumour cell metastatic potential in terms of adhesive properties and migratory response. Following exposure to subclotting concentrations of thrombin, SW-480 human colon adenocarcinoma cells exhibited increased adhesion to both the endothelium and ECM component (i.e. fibronectin). Likewise, the pretreatment of thrombin enhanced the migratory ability of SW-480 cells. The enhanced adhesion was significantly inhibited by complexing of thrombin with its inhibitor hirudin, or by serine proteinase inhibition with 3,4-DCI, but was unaffected by pretreatment of tumour cells with actinomycin D or cycloheximide. The effect of thrombin resulted in an upregulated cell-surface expression of beta 3 integrins, a group of receptors mediating interactions between tumour cells and endothelial cells, and between tumour cells and ECM. Antibodies against beta 3 integrins effectively blocked both the enhanced adhesion and migration. This thrombin-mediated up-regulation of beta 3 integrins involved the activation of protein kinase C (PKC) as thrombin-enhanced adhesion was diminished by PKC inhibition. Rhodostomin, an Arg-Gly-Asp-containing antiplatelet snake venom peptide that antagonises the binding of ECM toward beta 3 integrins on SW-480 cells, was about 600 and 500 times, more potent that RGDS in inhibiting thrombin-enhanced adhesion and migration respectively. Our data suggest that PKC inhibitors as well as rhodostomin may serve as inhibitory agents in the prevention of thrombin-enhanced metastasis.
Similar articles
-
Characterization of integrin expression and regulation on SW-480 human colon adenocarcinoma cells and the effect of rhodostomin on basal and upregulated tumor cell adhesion.Biochim Biophys Acta. 1994 Dec 30;1224(3):506-16. doi: 10.1016/0167-4889(94)90288-7. Biochim Biophys Acta. 1994. PMID: 7803510
-
The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells.Br J Cancer. 1995 Feb;71(2):265-70. doi: 10.1038/bjc.1995.54. Br J Cancer. 1995. PMID: 7841039 Free PMC article.
-
Thrombin increases the metastatic potential of tumor cells.Int J Cancer. 1993 Jul 9;54(5):793-806. doi: 10.1002/ijc.2910540514. Int J Cancer. 1993. PMID: 7686887
-
Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo.Thromb Haemost. 1995 Jul;74(1):282-90. Thromb Haemost. 1995. PMID: 8578473 Review.
-
Cell adhesion and tumor metastasis.Princess Takamatsu Symp. 1994;24:99-105. Princess Takamatsu Symp. 1994. PMID: 8983067 Review.
Cited by
-
Thrombin-induced Migration and Matrix Metalloproteinase-9 Expression Are Regulated by MAPK and PI3K Pathways in C6 Glioma Cells.Korean J Physiol Pharmacol. 2011 Aug;15(4):211-6. doi: 10.4196/kjpp.2011.15.4.211. Epub 2011 Aug 31. Korean J Physiol Pharmacol. 2011. PMID: 21994479 Free PMC article.
-
Inhibitory effect of recombinant tyrosine‑sulfated madanin‑1, a thrombin inhibitor, on the behavior of MDA‑MB‑231 and SKOV3 cells in vitro.Mol Med Rep. 2024 Jul;30(1):114. doi: 10.3892/mmr.2024.13238. Epub 2024 May 17. Mol Med Rep. 2024. PMID: 38757335 Free PMC article.
-
Protease-activated receptors in cancer: A systematic review.Oncol Lett. 2011 Jul;2(4):599-608. doi: 10.3892/ol.2011.291. Epub 2011 Apr 8. Oncol Lett. 2011. PMID: 22848234 Free PMC article.
-
Protease-Activated Receptors in the Intestine: Focus on Inflammation and Cancer.Front Endocrinol (Lausanne). 2019 Oct 24;10:717. doi: 10.3389/fendo.2019.00717. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31708870 Free PMC article. Review.
-
Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells.Am J Pathol. 2003 May;162(5):1503-13. doi: 10.1016/S0002-9440(10)64283-6. Am J Pathol. 2003. PMID: 12707033 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical